Biotech

Biotech Matthew Herper

STAT Plus: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease

The Readout Meghana Keshavan

STAT Plus: FDA offers new guidelines for Covid-19 vaccine

The Readout Elaine Chen

STAT Plus: J.P. Morgan has officially jumped into early stage biotech investing

Biotech Meghana Keshavan

STAT Plus: FDA gets pointed input on ‘optimizing’ advisory committee panels

The Readout LOUD Adam Feuerstein and Allison DeAngelis

STAT Plus: Listen: Duchenne gene therapy setback, Alzheimer’s drug endorsement & why a STAT reporter buys weed (for journalism)

Biotech Sarah Owermohle, Allison DeAngelis, and Adam Feuerstein

STAT Plus: Biopharma execs cheer Supreme Court for upholding FDA authority in abortion pill case

The Readout Meghana Keshavan

With Avidity and Pfizer, gene therapy enters a phase

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: Will Geron be acquired? The long-short view

The Readout Elaine Chen

STAT Plus: What do Parkinson’s and obesity have in common?

Biotech Jason Mast

STAT Plus: Avidity Biosciences says its experimental drug showed potential against form of muscular dystrophy

Politics Rachel Cohrs Zhang and Elaine Chen

STAT Plus: Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices

The Readout Elaine Chen

Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know

Biotech Allison DeAngelis

STAT Plus: Biotech co-founded by entrepreneur Bob Langer is testing a new approach to developing obesity treatments

Biotech Elaine Chen and Adam Feuerstein

STAT Plus: FDA advisers unanimously recommend approval of Eli Lilly’s Alzheimer’s disease treatment

The Readout Meghana Keshavan

The biotech news you missed from the weekend

Biotech Helen Branswell

STAT Plus: Moderna says data show its combination Covid-flu vaccine generates a strong immune response

The Readout Meghana Keshavan

STAT Plus: Vanda Pharmaceuticals has another suitor

Biotech Jonathan Wosen and Meghana Keshavan

STAT Plus: At BIO, signs Congress’ tough stance on China is chilling biotech relationships

Biotech Matthew Herper and Elaine Chen

STAT Plus: FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted to a smaller group

The Readout Elaine Chen

Novavax will be able to supply Covid-19 vaccines this fall

Biotech Elaine Chen

STAT Plus: Eli Lilly’s obesity drug Zepbound improved liver scarring in mid-stage MASH study

The Readout Jason Mast

STAT Plus: Testing begins for a new form of PrEP

Biotech Adam Feuerstein, Matthew Herper, and Angus Chen

STAT Plus: ASCO Takeaways: Winners, snoozers, the China question, and the art of cancer care

The Readout Elaine Chen

STAT Plus: Operation Warp Speed but for rare disease

Adam's Take Adam Feuerstein

STAT Plus: Novartis is flashing warning signs about the fate of its newly acquired myelofibrosis drug

Biotech Jason Mast

STAT Plus: Illumina board agrees to spin off Grail, as divestment plans proceed

Biotech Matthew Herper, Adam Feuerstein, and Angus Chen

STAT Plus: ASCO Daily Recap: A CAR-T advance, money talk, and tossing the cancer treatment ‘sandwich’

Biotech Angus Chen

STAT Plus: At ASCO, AstraZeneca says its CAR-T therapy shrank solid liver tumors in early trial

The Readout Meghana Keshavan

STAT Plus: Can AstraZeneca make good on its promise?